Prenetics Global Limited Announces Proposed Public Offering

Prenetics Global Limited, a leading health sciences company, announced a proposed public offering of its Class A Ordinary Shares and common warrants. The proceeds from the offering will be used for the global expansion of its flagship consumer brand, IM8, and the strategic accumulation of Bitcoin as part of its dual-pronged health and wealth strategy. The offering is subject to market conditions, and there is no assurance regarding its completion, size, or terms. Dominari Securities LLC is acting as the sole placement agent for the offering. The offering is being made pursuant to an effective shelf registration statement on Form F-3, declared effective by the SEC on September 11, 2025. A preliminary prospectus supplement and accompanying shelf prospectus will be filed with the SEC and made available on its website.